📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

T-cell-mediated hypersensitivity to lumacaftor and ivacaftor in cystic fibrosis. (2022)

First Author: Semic-Jusufagic A

Attributed to: Development of a stepwise screening approach to assess the intrinsic immunogenicity of drugs and chemicals funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/pai.13815

PubMed Identifier: 35754124

Publication URI: http://europepmc.org/abstract/MED/35754124

Type: Journal Article/Review

Volume: 33

Parent Publication: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Issue: 6

ISSN: 0905-6157